Standard antituberculous therapy including isoniazid, rifampin, ethambutol, and pyrazinamide is widely used for the treatment of active tuberculosis. Its most important side effect is hepatotoxicity, ranging from asymptomatic transaminitis to fulminant hepatic failure. A 19-year-old woman was admitt
Postresection hepatic failure: Successful treatment with liver transplantation
β Scribed by Yuichiro Otsuka; John P. Duffy; Sammy Saab; Douglas G. Farmer; Rafik M. Ghobrial; Jonathan R. Hiatt; Ronald W. Busuttil
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 252 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20917
No coin nor oath required. For personal study only.
β¦ Synopsis
Postoperative liver failure (PLF) is a rare but often fatal complication of major hepatic resection. Use of orthotopic liver transplantation (OLT) for PLF remains undefined. We conducted a retrospective review of 435 patients who underwent hepatic resection between 1990 and 2004; 9 of them (2.0%) developed PLF. Indications for resection included primary hepatic malignancies (8), colonic metastases (2), and echinococcic cyst (1); all resections were multisegmental, 6 were extended, and 2 were lobectomies. A total of 7 patients underwent OLT at a mean of 25 days after resection. Patients developing PLF had significantly lower preoperative platelet counts and significant elevations of total bilirubin, direct bilirubin, prothrombin time, and international normalized ratio (INR) by postoperative day 2. Pathological cirrhosis and extended right lobectomy were associated with significantly increased risk of PLF. Following OLT, there were no in-hospital deaths, but 1 patient required retransplantation for primary nonfunction. Mean survival with and without OLT was 42.2 and 1.4 months, respectively (P Ο 0.03). Following OLT, 1-and 5-yr patient survivals were 88% and 40%, respectively; 1-and 5-yr graft survivals were 75% and 34%, respectively. In conclusion, patients with low platelets, biopsy-proven cirrhosis, or those undergoing extended resection are at increased risk for PLF. OLT for PLF has significant morbidity but allows salvage of an otherwise fatal condition. Liver
π SIMILAR VOLUMES
Drug-induced liver disease accounts for about 50% of acute or subacute liver failure in the United States. United Network of Organ Sharing (UNOS) data suggest 8%-20% of liver transplantation in this country per year is for fulminant liver failure due to drugs. Even though the most common medication
s an indication for transplantation, fulminant A hepatic failure (FHF) accounts for approximately 7% of the liver transplantations currently performed in the United States and This percentage is very small in comparison with the number of transplants performed for chronic liver disease, but FHF domi